InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Silberstein Charles, Chief Financial Officer. Officer active across 1 companies, notably Applied Therapeutics Inc.. Cumulatively, 8 disclosures have been logged. Total volume traded: €178k. The latest transaction was filed on 14 December 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
047,900 shares0
Common Stock
SEC:0001209191-22-002967:0·
047,900 shares0
Common Stock
SEC:0001209191-22-002971·
047,900 shares0
Common Stock
SEC:0001209191-22-002967·
047,900 shares0
Common Stock
SEC:0001209191-22-002971:0·
047,900 shares0
Common Stock
SEC:0001209191-21-070085·
047,900 shares0
Common Stock
SEC:0001209191-21-070085:0·
€88,8105,047 shares@ €17.596550.0% of flow
Common Stock
SEC:0001209191-21-039723:0·
€88,8105,047 shares@ €17.5965100.0% of flow
Common Stock
SEC:0001209191-21-039723·
8 of 8 declarations
About Silberstein Charles
Charles Silberstein serves as Chief Financial Officer at Applied Therapeutics Inc. In this role, he is responsible for the financial management of the organization, including overseeing budgets and investments. His expertise in finance enables him to ensure effective management of financial resources and contribute to the overall strategy of the company. He plays a crucial role in financial planning and strategic decision-making.
